Urothelial Bladder Cancer
Also known as: Bladder Urothelial Cancer
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB09037 | Pembrolizumab | 1 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
| DB15627 | Dostarlimab | 2 | Suspended | 1 |
| DB11714 | Durvalumab | 2 | Completed | 1 |
| DB11793 | Niraparib | 2 | Suspended | 1 |
| DB11771 | Tremelimumab | 2 | Completed | 1 |
| DB11886 | Infigratinib | 3 | Terminated | 1 |